| Literature DB >> 29898139 |
Carlos Henrique Marques Dos Santos1, Doroty Mesquita Dourado1, Baldomero Antonio Kato da Silva2, Henrique Budib Dorsa Pontes1, Euler de Azevedo Neto1, Giovanna Serra da Cruz Vendas1, Ian de Oliveira Chaves1, João Victor Cunha Miranda1, João Victor Durães Gomes Oliva1, Letícia do Espírito Santo Dias1, Murillo Henrique Martins de Almeida1, Trícia Luna Sampaio1.
Abstract
OBJECTIVE: The aim of the present study was to evaluate the ability of ischemic postconditioning, atorvastatin and both associated to prevent or minimize reperfusion injury in the lung of rats subjected to ischemia and reperfusion by abdominal aortic clamping.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29898139 PMCID: PMC5985836 DOI: 10.21470/1678-9741-2017-0022
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Degree of histopathological lesion in the lung parenchyma in rats per group.
| Groups | |||||
|---|---|---|---|---|---|
| Rats | I/R | IPC | IPC+A | A | SHAM |
| 1 | 4 | 1 | 1 | 1 | 1 |
| 2 | 4 | 1 | 1 | 1 | 1 |
| 3 | 4 | 2 | 2 | 2 | 1 |
| 4 | 4 | 1 | 1 | 2 | 1 |
| 5 | 4 | 3 | 1 | 1 | 1 |
| 6 | 3 | 2 | 2 | 1 | |
| 7 | 2 | 1 | 1 | 1 | |
| 8 | 4 | 1 | 1 | 1 | |
| 9 | 4 | 2 | 1 | 1 | |
| Average | 3.6 | 1.6 | 1.2 | 1.2 | 1 |
Fig. 1Comparison of the medians of the degrees of lung injury among the different groups analyzed (Kruskal-Wallis P=0.0029; "a" P<0.01 in relation to I/R group; "b" P<0.001 in relation to I/R group).
Fig. 2Photomicrographs of histological changes of the pulmonary parenchyma of the I/R group considering the classification of Greca et al.[. Major changes are observed predominantly, grade 4: haemorrhage (h); blood vessel congestion (bvc); cell necrosis (black arrow); neutrophils (white arrow); alveolar wall (red arrow); focal edema (fe); fibrosis (f ). HE, 10x and 40x.
Fig. 6Photomicrographs of the pulmonary parenchyma of the SHAM group according to Greca et al.[. Focal edema (fe); alveolus (A). HE, 10x and 40x.
| Abbreviations, acronyms & symbols | |
|---|---|
| A | = Atorvastatin group |
| IPC | = Ischemic postcondictioning |
| IPC+A | = Postconditioning + atorvastatin group |
| IR | = Ischemia and reperfusion |
| I/R | = Ischemia and reperfusion group |
| ROS | = Reactive oxygen species |
| TNF | = Tumor necrosis factor |
| Authors' roles & responsibilities | |
|---|---|
| CHMS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| DMD | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| BAKS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| HBDP | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| EAN | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| GSCV | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| IOC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| JVCM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| JVDGO | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| LESD | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| MHMA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| TLS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |